Latham & Watkins Advises CNSI and Carlyle in Connection With CNSI’s Merger With Kepro

CNSI, a leading provider of innovative healthcare technology products and solutions, and Kepro, a leading provider of technology-enabled care management, quality oversight, and clinical assessment services announced an agreement to merge. The combined company will help government-sponsored healthcare agencies and payers expand healthcare access, enhance quality, improve health outcomes, and lower costs through its clinical services, provider management, health claims and encounter processing, interoperability, and health analytics services and solutions. CNSI is backed by funds advised by global investment firm Carlyle (NASDAQ: CG), and Kepro is a portfolio company of funds advised by Apax Partners LLP, which will be exiting its investment through this transaction.

Latham & Watkins LLP represents CNSI and Carlyle in the transaction with a M&A team led by Chicago partner Shaun Hartley and Washington, D.C. counsel Elizabeth More, and with assistance from Washington, D.C. partner Daniel Lennon. Advice was also provided on tax matters by New York partner David Raab; on benefits and compensation matters by Washington, D.C. partner David Della Rocca; and on debt financing matters by Washington, D.C. partners Jeffrey Chenard and Manu Gayatrinath.